About Us

Why Alkemi

Alkemi establishes patient access in a rapidly evolving, evidence-based, and value-conscious health policy environment. Our projects deliver strategic and tactical plans and often include design and execution of evidence studies, development and training on communication tools and participation or leadership of negotiations with regulator, payer, and institutional decision-makers to enable patient access.

Our Expertise

Decades of senior-level industry experience in medical and commercial roles

Strong methodological backgrounds across clinical, pharmacy and outcomes research

Experience negotiating novel payment and access arrangements across markets

Practical application of market access and evidence strategies

Our Values

Committed

We are 100% dedicated to your project and deadlines.

Collaborative

We respond promptly, communicate clearly, receive feedback openly, and work as an extension of your team.

Resourceful

We bring the necessary expertise and tools to deliver valuable results to you, our client.

Our Solutions

Leadership

View Bio

Betsy Lahue, CEO, brings over two decades of experience as a former health economics, outcomes research and market access healthcare executive. Ms. Lahue served on both Commercial and R&D leadership teams and regularly presented to the Board of Directors of a Fortune 500 healthcare company. Her experiences span all sectors of life science technology including pharma/biotech, medical device, and diagnostics. In rare diseases, Ms. Lahue had an opportunity to broker novel funding and access arrangements with national and regional authorities. As CEO of Alkemi, she provides strategic guidance to clients on product value assessments, evidence plans, regulatory endpoints and payer/HTA strategies to ensure patient access at the value-based price. Ms. Lahue earned a BA in Chemistry and English from Amherst College and her MPH from the Boston University School of Public Health. She currently serves on the Board of Directors for EvoEndo.

Betsy J. Lahue, MPH

CEO

Drives vision, strategy, and execution

View Bio

Robert Lahue, Chief Operating Officer, drives company growth and ensures financial efficiency in the pursuit of our mission. His business development and talent recruiting acumen spans healthcare, commercial real estate, and mixed investment portfolios. With over 20 years of financial management and strategic investment experience, he has successfully built and sold two businesses. Prior roles in industry include Regional Marketing Director and Sales Leader. Mr. Lahue earned a BS from Babson College.

Robert H. Lahue

COO

Manages business operations and client development

View Bio

Dr. Kristen Cribbs, Senior Research Director, leads policy, programmatic, and research ranging from study design and instrument development to quantitative and qualitative data collection and data analysis. The Alkemi research team under Dr. Cribbs’ supervision develops value messages, creates payer communication tools, and conducts systematic literature reviews, meta-analyses, and health economic modeling. Dr. Cribbs earned a PhD in Health Policy and Management from CUNY Graduate School of Public Health and Health Policy; an MPH in Sociomedical Sciences from Columbia University’s Mailman School of Public Health; and an AB in Psychology from Occidental College.

Kristen Cribbs, PhD, MPH

Senior Research Director

Oversees research operations and ensures excellence in all deliverables

Like the compass rose, the Alkemi logo has eight points symbolizing the true North orientation and direction we provide to our clients as they navigate a competitive and complex payment and access landscape.

Our colors, Green and Gold, represent Value and Access.

Gold: Lasting and rare value that is recognized with compelling outcomes evidence.

Green: The idea of patients given the “green light” by payers, guideline groups and HTA decision-makers for access to medical innovation.

Our History

Alkemi formed to provide Evidence and Access Support to innovative medical partners

Nov

2017

Engaged on five rare disease assets across two fortune 500 companies

Nov

2018

Evidence Communications: Payer dossiers and medical training decks

Mar

2019

Landscape Monitoring: Evidence insights

Sep

2020

Evidence Design and Analytical Support: Data Analysis

Feb

2021

HEOR Partner: Operational Support

Sep

2021

Global Expert Network: HEOR and Market Access Analysis

Jan

2022

Celebrating 5 years of excellence in Health Economics and Outcomes Research, and Market Access Consulting!

Nov

2022

Recognized by Inc. Magazine 2023: Fastest-Growing Companies at #37 in the Northeast United States

Feb

2023

Alkemi Ranks No. 395 on the Inc. 5000 - Among America's Fastest-Growing Private Companies

Aug

2023

Our Vision Statement

“Alkemi advances public health and improves outcomes by increasing access to medical innovation.”

We are driven by our vision of advancing public health, delivering value in healthcare, and improving patient outcomes. Utilizing our healthcare experience and global payer expertise, we provide clients with strategic tools and resources required to bring medical innovation to patients. Our creativity and novel value demonstration approaches meet requirements for commercial enterprises, healthcare providers, and payers. In doing so, we ensure that patients have rapid access to the most effective and efficient treatments available.